Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 1.854
-0.046 (-2.42%)
May 27, 2026, 12:49 PM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 23.26 million as of May 27, 2026. Its market cap has decreased by -33.33% in one year.
Market Cap
23.26M
Enterprise Value
38.13M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.85
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has decreased from 26.85M to 23.26M, a decrease of -13.35%. That is a compound annual growth rate of -1.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 23.26M | -19.99% |
| Dec 30, 2025 | 29.08M | -54.90% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioceltix | 406.76M |
| Ryvu Therapeutics | 401.37M |
| BIOTON | 371.36M |
| Syn2bio | 310.45M |
| Synthaverse | 207.36M |
| Mabion | 117.34M |
| Poltreg | 112.41M |
| Molecure | 110.84M |